- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Antimicrobial Host-Defense Peptide · Educational Resource
Understanding LL-37 and Innate Immune Defense Research
Peptide Classification
Human cathelicidin antimicrobial peptide (37 amino acids)
Target Application in Literature
Investigational antimicrobial and wound-healing research
Administration Protocol in Studies
Subcutaneous (subq) pen delivery
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Antimicrobial Host-Defense Peptide · Educational Resource
Understanding LL-37 and Innate Immune Defense Research
01 — Overview
What is LL-37?
LL-37 is the only cathelicidin-family antimicrobial peptide found in humans, a 37-amino-acid fragment cleaved from its precursor protein hCAP18, and researchers use synthetic LL-37 to study the body's own first-line innate immune defenses.
To understand its biological role, it helps to think of LL-37 as part of the body's chemical alarm system—a molecule released at sites of infection or injury that both directly attacks invading microbes and signals nearby immune cells to respond.
Scientific literature categorizes LL-37 as an investigational compound. By studying a synthetic version of this naturally occurring host-defense peptide, researchers can evaluate its dual antimicrobial and immune-signaling roles under controlled laboratory conditions.
02 — How it works
How It Works: Membrane Disruption and Immune Signaling
The primary mechanism researchers evaluate when studying LL-37 is its capacity to directly disrupt the membranes of bacteria, fungi, and certain viruses through its amphipathic structure, which allows it to insert into and destabilize microbial cell walls.
Beyond direct antimicrobial action, studies also evaluate LL-37's role as a chemoattractant that recruits immune cells to sites of infection or injury, along with its contribution to wound re-epithelialization and new blood vessel formation during tissue repair.
Administration in Research
In modern observational studies and laboratory applications, delivery methodologies focus exclusively on the use of a subq pen (subcutaneous delivery). This delivery system is prioritized in current protocols because it allows for precise, localized, and highly controlled micro-dosing directly into the subcutaneous layer to observe systemic innate immune signaling effects.
03 — Areas of research
Summary of Investigated Research Areas
Ongoing preclinical and clinical studies evaluate LL-37 across several key physiological systems, particularly relating to antimicrobial defense, wound healing, and innate immune modulation.
Broad-Spectrum Antimicrobial Activity
Clinical literature evaluates LL-37's direct membrane-disrupting effects against bacteria, fungi, and select viruses.
Wound Healing & Re-Epithelialization
Studies examine LL-37's contribution to keratinocyte migration and faster wound closure in tissue models.
Angiogenesis Support
Research investigates LL-37's role in stimulating new blood vessel formation during the tissue repair process.
Immune Cell Chemotaxis
Investigations evaluate LL-37's ability to recruit neutrophils, monocytes, and T cells to sites of infection or injury.
Anti-Biofilm Research
Studies assess LL-37's activity against bacterial biofilms, which are often resistant to conventional antibiotics.
Autoimmune Complex Formation Research
Comparative literature explores LL-37's dual role, including its studied association with self-DNA complexes implicated in certain autoimmune skin conditions.
04 — FAQ
Frequently Asked Questions
Ano ba ang LL-37 at para saan ito?
Ang LL-37 ay ang tanging cathelicidin antimicrobial peptide na natural na ginagawa ng katawan ng tao, at ginagamit ang synthetic version nito para pag-aralan ang first-line na depensa ng immune system laban sa mga bacteria, fungi, at virus.
Approved ba ng FDA ang LL-37?
Like many advanced peptide protocols, LL-37 is not a mass-manufactured, off-the-shelf medication, meaning it does not go through the standard FDA approval process designed for commercial retail drugs. Instead, medical-grade peptides are utilized as specialized, investigational therapies.
Kumbaga, they are custom-prepared rather than mass-produced. Sa Pilipinas at globally, accessing these types of biological protocols safely requires a thorough medical consultation and a doctor’s prescription. When properly prescribed, they are formulated by strictly regulated, licensed compounding pharmacies.
Paano ginagamit ang LL-37 sa mga scientific studies?
Current research and application protocols focus strictly on the use of a subq pen for delivery. This method is utilized by researchers to ensure highly accurate, controlled administration when evaluating the peptide’s antimicrobial and immune-signaling effects.
What makes it different from other biological compounds?
Unlike peptides that target a single receptor pathway, LL-37 is unique because literature highlights its dual role: it directly disrupts microbial membranes while also acting as a signaling molecule that recruits immune cells and supports tissue repair. Researchers are specifically interested in how one molecule can perform both functions simultaneously.
05 — References
References and Academic Literature
Dürr, U. H., Sudheendra, U. S., & Ramamoorthy, A. (2006). LL-37, the only human member of the cathelicidin family of antimicrobial peptides.. Biochimica et Biophysica Acta, 1758(9), 1408-1425.
Carretero, M., Escámez, M. J., García, M., et al. (2008). In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37.. Journal of Investigative Dermatology, 128(1), 223-236.
Bucki, R., Leszczyńska, K., Namiot, A., & Sokołowski, W. (2010). Cathelicidin LL-37: a multitask antimicrobial peptide.. Archivum Immunologiae et Therapiae Experimentalis, 58(1), 15-25.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups